Endress+Hauser expands footprint in Waldheim

The company now has twice the space for developing and manufacturing liquid analysis sensors and components Endress+Hauser Liquid Analysis invested around 35 million euros in the new building, effectively doubling the Waldheim site’s usable floor area to over 18,000 square meters. The three-story annex houses new production facilities, a logistics center with a fully automated [...]

SPT Labtech and Alithea Genomics Collaborate to Automate Ultra Sensitive Single-Cell Transcriptomic Workflows

Integrates Alithea Genomics’ MERCURIUS FLASH-seq single-cell RNA-seq protocol with SPT Labtech’s firefly liquid handling platform Enables higher-throughput, cost efficient single-cell sequencing Cambridge, UK, and Lausanne, Switzerland -- SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and Alithea Genomics, a pioneer in the field of large-scale RNA sequencing [...]

NanoTemper Strengthens Biopharma Discovery Portfolio with Acquisition of Envue Technologies and Launch of Dianthus™ α

NanoTemper Strengthens Biopharma Discovery Portfolio with Acquisition of Envue Technologies and Launch of Dianthus™ α NanoTemper’s two strategic milestones – NSM technology acquisition and the launch of Dianthus™ α application – expand its capabilities across the life sciences value chain and enhance support for the discovery of next-generation therapeutics. The Envue Technologies acquisition brings Nanofluidic Scattering [...]

Novogene Expands UK Offerings with Launch of ONT-Based Whole Plasmid Sequencing Service

CAMBRIDGE, England -- Novogene Europe is pleased to announce the launch of its new Whole Plasmid Sequencing service, powered by Oxford Nanopore Technologies (ONT). This service offering represents a major step forward in plasmid verification, providing researchers with a powerful and practical alternative to traditional Sanger sequencing. Unlike conventional approaches, whole plasmid sequencing delivers a [...]

Watchmaker Genomics Launches TAPS+, Expanding Multimodal Capabilities in Oncology Ahead of AMP 2025

- TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research. - Preserves DNA integrity in challenging clinically relevant samples, including FFPE tissue and circulating tumor DNA (ctDNA). - Platform-agnostic chemistry enables seamless integration across sequencing systems. BOULDER, Colo. -- Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology [...]

Atinary, ABB, Mettler-Toledo, and Agilent are building the first Self-Learning and Self-Driving Lab of its kind

Atinary collaborates with ABB Robotics, Mettler-Toledo, and Agilent to launch the first Self-Driving Lab of its kind in accelerating molecular discovery. We are thrilled to announce Atinary’s collaboration with ABB Robotics to build our first Self-Driving Lab for small-molecule synthesis. The new Atinary Lab will be in Boston. This project brings together Atinary’s pioneering AI-driven platform with [...]

Touchlight Expands mbDNA™ Portfolio with New Circular DNA Architectures for Advanced Therapies

LONDON, UK -- Touchlight, a leader in cell-free DNA technology, today announced the expansion of its groundbreaking mbDNA™ platform with the introduction of three new circular DNA architectures: sscDNA, hsscDNA, and dscDNA. These innovative constructs join mbDNA, which debuted earlier this year, to form a comprehensive portfolio designed to overcome the limitations of traditional gene editing tools. [...]

Illumina Responds to Positive Updates from Chinese Ministry of Commerce

SAN DIEGO -- The Chinese Ministry of Commerce (MOFCOM) today announced it will lift the export ban on Illumina, Inc. (NASDAQ: ILMN), which had been in place since March 4, 2025. While the ban will be lifted on November 10, Illumina remains on the Unreliable Entities List (UEL), requiring government approval for instrument purchases. Illumina remains focused [...]

Nightingale Health partners with Alamar Biosciences to expand its unique multiomics offering with ultra-sensitive proteomics for brain health

Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF), a pioneer in disease risk detection and global leader in metabolomics, announces a strategic partnership with Alamar Biosciences to integrate cutting-edge brain health proteomics into its multiomics portfolio. This collaboration enables comprehensive multiomics analysis from a single blood sample – available only from Nightingale Health. Nightingale Health’s [...]

Ginkgo Bioworks Awarded Project Agreement through BARDA’s BioMaP-Consortium

Ginkgo and Partners to Develop Monoclonal Antibody Biomanufacturing Innovations and to Produce an Anti-Filovirus Medical Countermeasure BOSTON -- Ginkgo Bioworks (NYSE: DNA) announced today that it has been awarded a contract through the Biomedical Advanced Research and Development Authority's (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) to develop innovations that strengthen and reduce the costs of domestic [...]

Access IBO on Knowledge Center